Celsius Gets Outperform Rating as Bernstein Starts Coverage on Five Beverage Stocks
Bernstein also rated Monster, Coca-Cola, PepsiCo, and Keurig Dr Pepper.
Already have an account? Sign in.
Bernstein also rated Monster, Coca-Cola, PepsiCo, and Keurig Dr Pepper.
Tempest gets an exclusive option to license Senlang’s CD7-targeted lentiviral in-vivo CAR-T, now in Phase 1 for relapsed multiple myeloma.
Axon plans $1 billion of 0% convertible notes due 2031, plus a $150 million option.
Senators failed to reach 60 votes on the Clarity Act. All Democrats and four Republicans stopped debate on digital asset rules.